PHARMA LARA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
04-02
micro format · 4 days late
2025
30-06
Financial
Liquidity more than triplescurrent ratio 9.70
The current ratio rises from 2.62 to 9.70. Short-term debt falls from €4,922 to €2,834.
30-01
micro format · 1 day before the deadline
2022
15-09
Gazette deed
IncorporationStarting capital €2,500 · Appointment: KOTOB Hassan (director) · Founder12 points ▸
Gazette deed
Incorporation
Starting capital €2,500 · Appointment: KOTOB Hassan (director) · Founder12 points ▸
- Founder, KOTOB Hassan
- Incorporation, 12-09-2022
- Other provision, “vérification d'identité, carte d'identité et registre national” (deed in French)
- Other provision, “capacité juridique” (deed in French)
- Other provision, 24-08-2022
- Founding capital, €2,500
- Capital, €2,500
- General meeting, “société étant constituée comparant se réunit, fixer nombre administrateurs et commissaires nomination administrateurs non statutaires et commissaire première as…” (deed in French)
- Board rule, 1
- Director appointment, KOTOB Hassan (director)
- Registered office clause, “1040 Etterbeek,Boulevard Louis Schmidt 93 boîte 12” (deed in French)
- Pre-incorporation commitments, ratification, “toutes opérations par comparant au nom société en formation et depuis ce jour” (deed in French)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
PHARMA LARA was incorporated on 13 September 2022 as a private limited company by one natural person, with a starting capital of €2,500.12 KOTOB Hassan is director of the company, appointed in the act of 15-09-2022.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3